Elon Musk Reveals ‘COVID’ Vaccine Injury After Former Pfizer Official Admits Shots Likely Killed Tens of Thousands in Germany

April 23, 2026 antivax

In an X post that went viral Sunday, Elon Musk said he “felt like I was dying” and almost went to the hospital after taking his second COVID-19 vaccine. Musk was responding to an X post about how Dr. Helmut Sterz, Pfizer’s former chief toxicologist, admitted during a German COVID-19 inquiry that an estimated 60,000 Germans died from Pfizer’s COVID-19 vaccine.

In an X post that went viral Sunday, Elon Musk said he “felt like I was dying” and almost went to the hospital after taking his second COVID-19 vaccine.

Musk was responding to an X post about how Dr. Helmut Sterz, Pfizer’s former chief toxicologist, admitted last month during a German COVID-19 Inquiry that an estimated 60,000 people have died in Germany from Pfizer’s mRNA COVID-19 vaccine, Comirnaty.

The vaccine dosage was obviously too high and done too many times.

I had the original Wuhan virus before there was any vaccine and it was much like any other cold/flu. Bad, but not terrible.

But my second vaccine shot almost sent me to the hospital. Felt like I was dying. https://t.co/rFuUpzBkKH

— Elon Musk (@elonmusk) April 12, 2026

According to Sterz, the Paul Ehrlich Institute, Germany’s regulatory and research institute for vaccines and biomedicines, has received 2,133 reports of death following Pfizer’s COVID-19 vaccine.

He said, “These spontaneous reports likely have a high number of unreported cases due to underreporting. The true number is therefore much higher.”

“In the U.S., it is assumed that there is an underreporting factor of 30 by which the registered cases would have to be multiplied. For Germany, this would correspond to 60,000 deaths from the vaccination,” Sterz said.

Sterz told the German commissioners that Pfizer’s post-marketing report mentioned 1,200 suspected deaths within just two months of the shot’s approval.

“At that point, Comirnaty should have been withdrawn from the market,” Sterz said.

Pfizer skipped key safety studies due to ‘time constraints’